SCHEMBL14223162

SCHEMBL14223162

C=C(OCC)c1ccc2c(c1)CCCc1cnc(-c3cccnc3)nc1-2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.39
▸ KDM2B Q8NHM5 1/20 0.38
▸ NPY5R Q15761 3/20 0.37
▸ CYP11B1 P15538 5/20 0.37
▸ CYP11B2 P19099 5/20 0.37
▸ CYP19A1 P11511 4/20 0.37
▸ CYP3A4 P08684 2/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ S1PR1 P21453 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14172845 0.89 ACHE (0.51) ACHEKDM2BCYP11B1CYP11B2CYP19A1
SCHEMBL14172846 0.79 CYP11B1 (0.47) NPY5RCYP11B1CYP11B2CYP19A1CYP3A4
SCHEMBL14172825 0.77 CYP11B1 (0.43) NPY5RCYP11B1CYP11B2CYP19A1CYP3A4
SCHEMBL14223000 0.77 NPY5R (0.38) NPY5RCYP11B1CYP11B2CYP3A4LMNA
SCHEMBL14172847 0.74 CYP3A4 (0.41) NPY5RCYP11B1CYP11B2CYP19A1CYP3A4
SCHEMBL14172826 0.73 CHRNB2 (0.48) CYP11B1CYP11B2CYP19A1CYP3A4LMNA
SCHEMBL14172610 0.72 CYP2C9 (0.43) CYP11B2MAPTSMN1; SMN2CYP2C9NPC1
SCHEMBL14172607 0.70 NPY5R (0.37) NPY5RCYP11B1CYP11B2CYP3A4LMNA
SCHEMBL14172611 0.70 STIM1 (0.41) NPY5RCYP11B1CYP11B2CYP3A4MAPT
SCHEMBL14172608 0.69 NPC1 (0.48) CYP11B1CYP11B2LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008039520-A2 FUSED RING COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2008-04-03 — — WO disclosed
Send feedback